Czechia· CZ-0223170

PRIMOVIST

A gadoxetsäure product containing disodium gadoxetate, registered in Czechia by Bayer AG, Leverkusen. The same ATC class is registered in 12 of our 19 countries.

ATC V08CA10

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedPRIMOVISTATCV08CA10REGISTER NO.CZ-0223170PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Gadoxetsäure is registered in 12 of 19 countries.

Countries holding a registration under ATC V08CA10 (gadoxetsäure), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Gadoxetsäure · ATC V08CA10

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
DISODIUM GADOXETATE
Manufacturer
Bayer AG, Leverkusen
Country
Czechia (CZ)
ATC code
V08CA10
ATC class
Gadoxetsäure
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0223170
    1X10ML I
    CZK 4201.69

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

34 interactions on record for gadoxetsäure.

Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Gadoxetsäure · interactions on record

34 records

  • 34 moderate

Most severe, free to view

  • PindololC07AA03moderate
  • PropranololC07AA05moderate
  • TimololC07AA06moderate
  • SotalolC07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/78079175-da5b-4b96-9092-c8666e7cb890
GET /v1/drugs/78079175-da5b-4b96-9092-c8666e7cb890?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SOL ISP",
  "source": "sukl",
  "strength": "0,25MMOL/ML",
  "pack_size": "1X10ML I",
  "substance": "DISODIUM GADOXETATE",
  "cz_kod_sukl": "0223170",
  "product_type": "CH",
  "substance_codes": "3257",
  "registration_state": "R",
  "registration_number": "48/178/04-C"
}

See everything about gadoxetsäure.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.